MKI67 and COVID-19: Considering that some data suggest that CD8+ T cells may have a hyperactivation signature in patients with severe COVID-19 [44,45,46], this might imply that strong CD38+HLA-DR+ or Ki67+ T cell activation could underline virus-specific CD8+ T cell responses in those patients [47,48].